Stifel boosts target: Social media buzz centers on Stifel's reiterated Buy rating for Astera Labs, with the price target lifted to $236. Investors note sustained hyperscaler demand fueling earnings potential amid robust product momentum. This upgrade underscores expectations for multiple growth cycles ahead.
Breakout signals emerge: Traders on social media point to higher highs and lows, signaling whale accumulation in the stock. A breakout above recent resistance could target significantly higher levels, drawing buy-on-strength calls. Pullbacks to key support levels are eyed as entry opportunities.
AI connectivity demand: Discussion highlights Astera Labs' critical role in AI data centers, addressing connectivity bottlenecks for GPUs and memory. Partnerships with major chipmakers bolster optimism for its position in the expanding AI infrastructure market. The sentiment reflects broad enthusiasm for its technological edge.
Note: This discussion summary was generated from an AI condensation of post data.
Astera Labs Insider Trading Activity
Astera Labs insiders have traded $ALAB stock on the open market 151 times in the past 6 months. Of those trades, 0 have been purchases and 151 have been sales.
Here’s a breakdown of recent trading of $ALAB stock by insiders over the last 6 months:
- JITENDRA MOHAN (Chief Executive Officer) has made 0 purchases and 34 sales selling 805,528 shares for an estimated $122,464,089.
- MANUEL ALBA has made 0 purchases and 45 sales selling 366,000 shares for an estimated $50,104,598.
- SANJAY GAJENDRA (President and COO) has made 0 purchases and 10 sales selling 185,430 shares for an estimated $24,847,049.
- PHILIP MAZZARA (General Counsel and Secretary) has made 0 purchases and 31 sales selling 39,469 shares for an estimated $5,305,278.
- STEFAN A DYCKERHOFF has made 0 purchases and 6 sales selling 24,998 shares for an estimated $4,376,257.
- MICHAEL TRUETT TATE (Chief Financial Officer) has made 0 purchases and 9 sales selling 23,431 shares for an estimated $3,139,643.
- JACK R LAZAR has made 0 purchases and 16 sales selling 12,500 shares for an estimated $1,597,344.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API.
Astera Labs Revenue
Astera Labs had revenues of $270.6M in Q4 2025. This is an increase of 91.77% from the same period in the prior year.
You can track ALAB financials on Quiver Quantitative's ALAB stock page.
Astera Labs Hedge Fund Activity
We have seen 404 institutional investors add shares of Astera Labs stock to their portfolio, and 352 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- BLACKROCK, INC. added 1,739,429 shares (+15.5%) to their portfolio in Q4 2025, for an estimated $289,371,408
- ATREIDES MANAGEMENT, LP added 1,549,144 shares (+2496.6%) to their portfolio in Q4 2025, for an estimated $257,715,595
- MASSACHUSETTS FINANCIAL SERVICES CO /MA/ removed 1,507,675 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $250,816,813
- FMR LLC added 1,255,455 shares (+5.2%) to their portfolio in Q4 2025, for an estimated $208,857,493
- ARTISAN PARTNERS LIMITED PARTNERSHIP added 895,530 shares (+inf%) to their portfolio in Q4 2025, for an estimated $148,980,370
- BARCLAYS PLC removed 864,776 shares (-42.9%) from their portfolio in Q4 2025, for an estimated $143,864,135
- DRIEHAUS CAPITAL MANAGEMENT LLC removed 822,560 shares (-99.7%) from their portfolio in Q4 2025, for an estimated $136,841,081
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API.
Astera Labs Analyst Ratings
Wall Street analysts have issued reports on $ALAB in the last several months. We have seen 4 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Loop Capital issued a "Buy" rating on 03/05/2026
- RBC Capital issued a "Outperform" rating on 01/15/2026
- BNP Paribas Exane issued a "Outperform" rating on 11/20/2025
- Northland Capital Markets issued a "Outperform" rating on 11/17/2025
To track analyst ratings and price targets for Astera Labs, check out Quiver Quantitative's $ALAB forecast page.
Astera Labs Price Targets
Multiple analysts have issued price targets for $ALAB recently. We have seen 8 analysts offer price targets for $ALAB in the last 6 months, with a median target of $212.5.
Here are some recent targets:
- Mike Harrison from Rothschild & Co set a target price of $153.0 on 05/01/2026
- Natalia Winkler from UBS set a target price of $180.0 on 04/21/2026
- Papa Sylla from Citigroup set a target price of $200.0 on 04/02/2026
- Ananda Baruah from Loop Capital set a target price of $250.0 on 03/05/2026
- Srini Pajjuri from RBC Capital set a target price of $225.0 on 01/15/2026
- Gus Richard from Northland Capital Markets set a target price of $195.0 on 12/09/2025
- Karl Ackerman from BNP Paribas Exane set a target price of $225.0 on 11/20/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
